Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, China.
Wenzhou Medical University RenJi College, Wenzhou 325000, Zhejiang, China.
Can J Gastroenterol Hepatol. 2019 Dec 19;2019:8748459. doi: 10.1155/2019/8748459. eCollection 2019.
Limited studies have preliminarily identified a positive association between nonalcoholic fatty liver disease (NAFLD) and hemoglobin glycation index (HGI). However, this association has not been fully established. We aim to investigate the association between NAFLD and HGI in Chinese nondiabetic individuals and to construct a risk score based on HGI to predict a person's risk of NAFLD.
After strict exclusion criteria, 5,903 individuals were included in this retrospective cross-sectional study. We randomly selected 1,967 subjects in the enrollment to obtain an equation of linear regression, which was used to calculate predicted HbA1c and drive HGI. The other subjects were classified into four categories according to HGI level (≤-0.22, -0.21∼0.02, 0.03∼0.28, and ≥0.29). All subjects retrospectively reviewed the baseline characteristics, laboratory examinations, and abdominal ultrasonography.
The prevalence of NAFLD in this population was 20.7%, which increases along with the growth of HGI levels ( < 0.001). Adjusted to multiple factors, this trend still remained significant (OR: 1.172 (95% CI, 1.074-1.279)). The combined NAFLD risk score based on HGI resulted in an area under the receiver operator characteristic curve (AUROC) of 0.85 provided sensitivity, specificity, positive predictive value, and a negative predictive value for NAFLD of 84.4%, 71.3%, 65.0%, and 88.0%, respectively.
NAFLD is independently associated with HGI levels in Chinese nondiabetic individuals. And, NAFLD risk score may be used as one of the risk predictors of NAFLD in nondiabetic population.
有限的研究初步确定非酒精性脂肪性肝病(NAFLD)与血红蛋白糖化指数(HGI)之间存在正相关。然而,这种相关性尚未完全确立。我们旨在调查中国非糖尿病个体中 NAFLD 与 HGI 之间的关联,并构建基于 HGI 的风险评分来预测个体患 NAFLD 的风险。
在严格排除标准后,共有 5903 名个体纳入本回顾性横断面研究。我们从入组人群中随机选择 1967 名个体获得线性回归方程,用于计算预测的 HbA1c 并驱动 HGI。其余个体根据 HGI 水平分为 4 类(≤-0.22、-0.21∼0.02、0.03∼0.28 和≥0.29)。所有个体均回顾性地审查了基线特征、实验室检查和腹部超声。
该人群中 NAFLD 的患病率为 20.7%,随着 HGI 水平的升高而增加(<0.001)。调整多个因素后,这种趋势仍然显著(OR:1.172(95%CI,1.074-1.279))。基于 HGI 的联合 NAFLD 风险评分得出的接受者操作特征曲线(AUROC)下面积为 0.85,提供了对 NAFLD 的 84.4%、71.3%、65.0%和 88.0%的敏感性、特异性、阳性预测值和阴性预测值。
NAFLD 与中国非糖尿病个体的 HGI 水平独立相关。并且,NAFLD 风险评分可能可作为非糖尿病人群中 NAFLD 的风险预测指标之一。